AU Pharma and Biotech Project, Program and Portfolio Management Conference
MELBOURNE | 2025
International in-person conference filled with leading industry speakers.
key information
- Location: Hyatt Centric Melbourne 25 Downie St Melbourne, Victoria, 3000 Australia
- Part of the PPM World Tour
- September 3-4, 2025
- 9:00 - 17:30 Local Time
What to expect
The AU Pharma and Biotech Project, Program and Portfolio Management Conference is the premier gathering for life sciences executives, portfolio leaders, and decision-makers in pharma, biotech, medtech, and diagnostics. As the Australian life sciences industry continues to evolve into a global leader in innovation, strategic portfolio management has never been more critical. This conference provides a deep dive into the latest trends, challenges, and best practices for optimizing portfolio performance, enhancing decision-making, and leveraging AI and digital transformation for business success.
Through insightful keynotes, case studies, panel discussions, and interactive roundtables, attendees will gain actionable strategies to drive innovation, balance risk, and execute high-impact portfolio decisions in an increasingly complex and competitive market.
Main takeaways
- Balancing Innovation, Risk, and Execution in Life Sciences Portfolios Discover how to navigate funding constraints and regulatory complexity while optimizing portfolio decision-making to drive growth and impact.
- From Overloaded to Optimized – Smarter Portfolio Prioritization: Learn how to master resource allocation, trade-offs, and scenario planning to maximize ROI and keep your projects on track in a competitive market.
- AI & Advanced Analytics – The Future of Project & Portfolio Management: Uncover how predictive modeling, real-time dashboards, and automation are transforming forecasting, risk assessment, and execution speed.
- Agility in PPM – Balancing Flexibility with Compliance: Explore how to implement hybrid and agile methodologies while ensuring regulatory adherence in an evolving pharma and biotech landscape.
- Scaling PPM from Strategy to Execution: Overcome execution bottlenecks and cross-functional misalignment to ensure seamless project delivery and business success.
Target audience breakdown:
- Portfolio & Program Managers – Responsible for overseeing multiple projects and ensuring strategic alignment.
- R&D Leaders – Managing innovation pipelines and investment decisions.
- Business & Corporate Strategy Executives – Driving long-term growth through effective portfolio prioritization.
- Financial & Investment Managers – Assessing ROI and risk mitigation in portfolio execution.
- Regulatory & Compliance Professionals – Navigating complex regulations while maintaining project agility.
- AI, Data Science & IT Leaders – Leveraging digital tools for predictive analytics and decision support.
- Clinical Development Executives – Streamlining clinical trial efficiency through better resource management.
- Mergers & Acquisitions (M&A) Specialists – Aligning portfolio strategy with corporate growth objectives.
- Innovation & Digital Transformation Leaders – Exploring AI, automation, and cutting-edge tools for PPM success.
Everything you need to know about this event in one spot.
Check out our event overview and agenda and discover this conference.
Event Partners
GOLD Sponsor
Powering enterprise project excellence across industries Celoxis is the all-in-one project and portfolio management platform trusted by global leaders.
From strategic planning and resource management to financial tracking and AI-powered insights Celoxis brings clarity and control to complex project environments.
With rapid deployment, deep configurability and out-of-box functionality, Celoxis enables teams to plan smarter, execute faster and deliver results—at scale.
Whether you’re managing internal initiatives or client-facing programs Celoxis helps you turn strategy into action effortlessly.
Silver Sponsor
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations.
Event Speakers
Amanda Mao
Alliance Management Lead
Keros Therapeutics
Anne Woollett
Clinical Trials Director, TrialHub
Alfred Health
Annette Murphy
Head of Scientific Operations
Incisive Technologie
Anubhav Srivastava
Director, Drug Development
Dimerix Biosciences
Ben Laverty
Vice President, Clinical Operations
IQVIA
Chris Quinn
Director, CMC Lead, Head of CMC Science
CSL
Debra Bourke
Interim Supporting Vice President
Medical Affairs Professionals of Australasia (MAPA)
Divya Pasupuleti
President
PMI Melbourne Chapter
Emma Pinkerton
Director, Global Site Management
Abbvie
Fardaad Choksey
Associate Medical Director, Oncology – ANZ
Astrazeneca
Industry Pioneers Attending From
Testimonials
Rated 5 out of 5
It was a real pleasure being part of this great event.
Blerim Shkodra
Sr Director Capital Procurement & Category Leader, Lonza
Rated 5 out of 5
I had the pleasure of assisting this year to the first two days of the Portfolio Summit in Basel, where +100 colleagues of +30 companies, discussed the topics of Portfolio, Projects, and CapEx in a very open and inviting environment. (Big thanks to Why Summits and especially to Liza Zhaivoronok for your help). I am very much looking forward to the 2025 Summit!
Carlos Cabrera
Head of Finance and Resources - Portfolio Creation and Technology, Bayer
Rated 5 out of 5
It was a very transparent discussion on Agile, waterfall and hybrid methodologies. I have fully enjoyed participanting in this panel!
Mugunthan Maheswaran
Sr Project Manager, Technology, Digital & Operational Excellence, Roche
Rated 5 out of 5
Thanks for the opportunity to share lessons learned at the conference. Also, very well planned and managed event with great speakers and highly relevant network.
Peter C. Luke
Project Corporate Vice President - API Expansion, Novo Nordisk
Rated 5 out of 5
Very good and engaging discussion! Thanks Why Summits for being part of the panel.
Christophe De Vleeschouwer
Director, Pipeline Project Management, GSK Vaccines
Rated 5 out of 5
It was an honor to be part of such a prestigious event and to contribute to discussions. Thanks Why Summits for the opportunity to engage with such a knowledgeable audience and networking with industry leaders !!
Dhawal Upadhyay, PMP®, HBS
General Manager - Global Program Management, Intas Pharmaceuticals
REGISTRATION
Conference
Ticket | September 3-4, 2025
AUD$
3399
-
Access to All Conference Sessions of thePharma and Biotech Project, Program and Project Management Conference Australia 2025
-
Access to Post Conferences Networking
-
Conference Materials
-
Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch
BECOME A PARTNER
OF this EVENT-
Present on the Main Stage
-
Hold an exhibit at this event
-
Showcase your Brand in Marketing Material
-
Gain exposure through alternative partnership benefits
